Back

Farnesylation of RhoB: the cancer hypothesis of pulmonary hypertension revisited

Cardiovascular Research

28 February 2017
Organised by: Logo
Read full article
ESC Journals

Contributors

Daphne Merkus
Daphne Merkus

Author

Walter Brendel Centre Munich , Germany

Ralph T. Schermuly
Ralph T. Schermuly

Author

You may be interested in
thumbnail
Congress Presentation
Metabolic reprogramming in pulmonary arterial hypertension: is it a cancer-like disease?
27 August 2021
thumbnail
Congress Presentation
Microvesicle markers of pulmonary hypertension
1 September 2025
thumbnail
Congress Presentation
Increased bone morphogenetic protein 10 in precapillary pulmonary hypertension patients
12 April 2024
thumbnail
Congress Presentation
Rimeporide, a first in class Na/H exchanger-1 inhibitor, ameliorates right ventricular dysfunction and pulmonary arterial hypertension in a SuHx model
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources